Starling Oncology, Inc.
STLN- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Starling Oncology, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +7 vs. Q1 2022
- Shares held
- 21.9M
- +814.1K (+3.9%) vs. Q1 2022
- Total value
- $110.9M
- −$48.1M (−30.2%) vs. Q1 2022
- New holders
- 16
- 9 more added
- Sold out
- 9
- 9 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $217.6M |
| Q1 2026 | 115 | $118.9M |
| Q4 2025 | 117 | $137.1M |
| Q3 2025 | 108 | $121.0M |
| Q2 2025 | 79 | $65.5M |
| Q1 2025 | 43 | $19.4M |
| Q4 2024 | 31 | $4.61M |
| Q3 2024 | 34 | $6.73M |
| Q2 2024 | 39 | $8.60M |
| Q1 2024 | 47 | $27.2M |
| Q4 2023 | 45 | $37.6M |
| Q3 2023 | 36 | $21.2M |
| Q2 2023 | 38 | $7.66M |
| Q1 2023 | 39 | $14.9M |
| Q4 2022 | 40 | $38.7M |
| Q3 2022 | 39 | $108.4M |
| Q2 2022 | 36 | $110.9M |
| Q1 2022 | 29 | $159.0M |
| Q4 2021 | 21 | $199.9M |
| Q3 2021 | 1 | $2.50M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 106 | $1.00K | 0.00% | −473−81.7% | Reduced |
| Credit Suisse AG | 246 | $1.00K | 0.00% | +246 | New |
| Wells Fargo & Company | 470 | $2.00K | 0.00% | +406+634.4% | Added |
| UBS Group AG | 513 | $3.00K | 0.00% | +513 | New |
| Barclays PLC | 941 | $5.00K | 0.00% | +941 | New |
| Morgan Stanley | 1,203 | $6.00K | 0.00% | −3,272−73.1% | Reduced |
| Citigroup Inc | 1,137 | $6.00K | 0.00% | +1,137 | New |
| Ameritas Investment Partners, Inc. | 1,409 | $7.00K | 0.00% | +1,409 | New |
| Penserra Capital Management LLC | 2,121 | $10.0K | 0.00% | −929−30.5% | Reduced |
| Amalgamated Bank | 2,969 | $15.0K | 0.00% | +2,969 | New |
| Legal & General Group Plc | 3,607 | $18.0K | 0.00% | +3,607 | New |
| Tower Research Capital LLC (TRC) | 3,688 | $19.0K | 0.00% | +2,873+352.5% | Added |
| Bank of America Corp | 6,251 | $31.0K | 0.00% | −3,387−35.1% | Reduced |
| California State Teachers Retirement System | 8,031 | $41.0K | 0.00% | +8,031 | New |
| American International Group, Inc. | 8,790 | $44.0K | 0.00% | +8,790 | New |
| Deutsche Bank AG | 9,447 | $48.0K | 0.00% | +9,447 | New |
| JPMorgan Chase & Co | 10,041 | $51.0K | 0.00% | +9,641+2,410.3% | Added |
| New York State Common Retirement Fund | 15,800 | $80.0K | 0.00% | +15,800 | New |
| First Republic Investment Management, Inc. | 18,300 | $93.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 22,487 | $114.0K | 0.00% | +22,487 | New |
| Bank of New York Mellon Corp | 37,455 | $190.0K | 0.00% | +37,455 | New |
| Charles Schwab Investment Management Inc | 41,261 | $209.0K | 0.00% | +41,261 | New |
| Nuveen Asset Management, LLC | 26,469 | $251.0K | 0.00% | +26,469 | New |
| Millennium Management LLC | 121,145 | $613.0K | 0.00% | −38,678−24.2% | Reduced |
| Northern Trust Corp | 143,921 | $729.0K | 0.00% | +125,856+696.7% | Added |
| Parian Global Management LP | 183,828 | $930.0K | 4.26% | −260,416−58.6% | Reduced |
| State Street Corp | 198,627 | $1.00M | 0.00% | +167,527+538.7% | Added |
| Geode Capital Management, LLC | 245,391 | $1.24M | 0.00% | +164,989+205.2% | Added |
| Hongkou Capital LP | 365,679 | $1.85M | 4.08% | −62,421−14.6% | Reduced |
| Saba Capital Management, L.P. | 367,292 | $1.86M | 0.03% | −32,708−8.2% | Reduced |
| Velan Capital Investment Management LP | 600,000 | $3.04M | 3.22% | 00.0% | Unchanged |
| BlackRock Inc. | 758,095 | $3.84M | 0.00% | +758,095 | New |
| Vanguard Group Inc | 1,575,435 | $7.97M | 0.00% | +737,114+87.9% | Added |
| Redmile Group, LLC | 1,736,116 | $8.79M | 0.34% | −678,316−28.1% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 3,383,099 | $17.1M | 0.36% | +86,992+2.6% | Added |
| FMR LLC | 12,000,078 | $60.7M | 0.01% | +780.0% | Added |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −106,505−100.0% | Sold out |
| Empery Asset Management, LP | 0 | $0 | 0.00% | −70,733−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −60,387−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −40,951−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −37,850−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,873−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,033−100.0% | Sold out |
| Ovata Capital Management Ltd | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −967−100.0% | Sold out |